Home » Stocks » NEOG

Neogen Corporation (NEOG)

Stock Price: $69.74 USD -0.01 (-0.01%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 3.70B
Revenue (ttm) 426.07M
Net Income (ttm) 60.68M
Shares Out 53.04M
EPS (ttm) 1.15
PE Ratio 60.64
Forward PE 55.25
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $69.74
Previous Close $69.75
Change ($) -0.01
Change (%) -0.01%
Day's Open 69.44
Day's Range 68.56 - 69.81
Day's Volume 346,963
52-Week Range 48.91 - 82.06

More Stats

Market Cap 3.70B
Enterprise Value 3.33B
Earnings Date (est) Dec 21, 2020
Ex-Dividend Date n/a
Shares Outstanding 53.04M
Float 52.86M
EPS (basic) 1.15
EPS (diluted) 1.15
FCF / Share 1.24
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.65%
FCF Yield 1.77%
Payout Ratio n/a
Shares Short 2.44M
Short Ratio 1.62
Short % of Float 4.62%
Beta 0.55
PE Ratio 60.64
Forward PE 55.25
P/FCF Ratio 56.51
PS Ratio 8.68
PB Ratio 4.82
Revenue 426.07M
Operating Income 70.15M
Net Income 60.68M
Free Cash Flow 65.46M
Net Cash 367.49M
Net Cash / Share 6.93
Gross Margin 46.07%
Operating Margin 16.47%
Profit Margin 14.20%
FCF Margin 15.36%
ROA 5.68%
ROE 8.60%
ROIC 14.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 1
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$81.50*
(16.86% upside)
Low
75.0
Current: $69.74
High
88.0
Target: 81.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue418414398358321283247208184173
Revenue Growth0.96%4.09%11.07%11.52%13.5%14.42%19.22%12.76%6.58%-
Gross Profit19619218616915314012310992.4387.79
Operating Income67.5268.0970.1964.9556.3953.1243.3940.7133.7435.84
Net Income59.4860.1863.1543.7936.5633.5328.1627.1922.5122.84
Shares Outstanding52.5551.8951.3650.8350.0349.3948.8947.8447.1146.38
Earnings Per Share1.131.151.210.860.720.680.570.560.470.48
EPS Growth-1.74%-4.96%40.7%19.44%6.67%18.42%1.24%21.08%-3.12%-
Operating Cash Flow85.8863.8469.1360.2735.3343.7921.6726.5622.2828.84
Capital Expenditures-24.05-14.66-20.95-14.58-14.22-9.62-11.54-8.90-12.41-7.80
Free Cash Flow61.8349.1848.1945.7021.1134.1710.1317.669.8621.05
Cash & Equivalents34426821114410811476.5085.3768.6556.08
Net Cash / Debt34426821114410811476.5085.3768.6556.08
Assets797696618528450392345291252220
Liabilities72.0157.8457.8356.6545.7841.2239.0032.2732.5530.68
Book Value725638560472404351306258219189
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Neogen Corporation
Country United States
Employees 1,764
CEO John E. Adent

Stock Information

Ticker Symbol NEOG
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: NEOG
IPO Date August 23, 1989

Description

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.